Key result
Elevated D-dimer levels were independently associated with an increased risk of long-term all-cause mortality in elderly patients with end-stage heart failure (P=0.048).
Why the study?
Elevated D-dimer levels are associated with poor prognosis in heart failure, but little is known about their clinical significance and determinants in elderly patients with end-stage heart failure.
Does elevated D-dimer level predict all-cause mortality in elderly patients with end-stage heart failure?
Cohort (n=177)
No
Does elevated D-dimer level predict all-cause mortality in elderly patients with end-stage heart failure?
Elevated D-dimer levels are independently associated with poor long-term outcomes in elderly patients with end-stage heart failure.
D-dimer may aid prognostication in elderly end-stage HF; leaves open incremental value over standard models.
Background Previous studies have shown that heart failure is associated with hemostatic abnormalities and hypercoagulable state. Plasma D-dimer levels reflect both fibrin formation and degradation, and elevated D-dimer levels have been associated with poor prognosis in patients with heart failure. However, little is known about their roles in elderly patients with end-stage HF. In present study, we aimed to explore the clinical significance and determinants of plasma D-dimer in elderly patients with end-stage heart failure. Methods A total of 177 patients with heart failure at Beijing Geriatric Hospital from November 1, 2015 to December 30, 2018 were enrolled. All hospitalized patients were obtained D-dimer levels within the first 24 h following admission after obtaining informed consent. Primary endpoint was all-cause mortality. Results A total of 60 patients had elevated D-dimer levels. Blood urea nitrogen (β = 1.106, 95% CI: 1.029–1.190, p = 0.006), NYHA functional class (β = 2.179, 95% CI: 1.170–4.056, p = 0.014) and white blood cell counts (β = 1.188, 95% CI: 1.040–1.358, p = 0.011) were independent risk factors for elevated D-dimer in elderly patients with end-stage heart failure. Albumin (β = 0.803, 95% CI: 0.728–0.885, P ༜ 0.001) was negative risk factor for elevated D-dimer in elderly patients with end-stage heart failure. Elevated D-dimer level was independently associated with increased risk of long-term all-cause mortality (P = 0.048). Conclusions For elderly patients with end-stage heart failure, D-dimer levels were associated with white blood cell counts, blood urea nitrogen, albumin and NYHA functional class and elevated D-dimer level was independently associated with poor long-term outcome.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2021) conducted a cohort in End-stage heart failure (n=177). Elevated D-dimer levels vs. Non-elevated D-dimer levels was evaluated on All-cause mortality (p=0.048). Elevated D-dimer levels were independently associated with an increased risk of long-term all-cause mortality in elderly patients with end-stage heart failure (P=0.048).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: